drug
cabotegravir sodium
Marketedupdated 3mo agoby ViiV Healthcare Company
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 4all catalysts(2)
Trials studying cabotegravir sodium
Patent cliff
source: FDA Orange Bookfirst barrier falls
Feb 4, 2031
~4.5 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (2)
- Feb 4, 2031compositionUS 84101034.5y
- Apr 28, 2026compositionUS 10927129
FDA exclusivities (1)
- Jan 21, 2026NCENew Chemical Entity (5y)
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 7m ago
Found something off?
comments(0)
5-min edit window · permanent after that